Dickler (CALGB 40503°, 2015 trial summary

A randomised clinical trial investigating the effect of Letrozole plus bevacizumab versus letrozole in



Studied treatment
Control treatment

Group sizes-9 / -9

Blindness Inclusion period
Follow-up duration Centers
Lost to FU geographical localisation
Primary endpoint Design

EndpointX1N1X0N0TE95% CI0,22,01,0

Dickler M, Barry WT, Cirrincione C, Ellis MJ, Moynahan ME, Innocenti F. Phase III trial evaluating the additionof bevacizumab to letrozole as first-line endocrine therapyfor treatment of hormone-receptor positive advancedbreast cancer: CALGB 40503 (Alliance). J Clin Oncol 2015;33 (suppl; abstr 501).     [PMID: ]   link to pdf   add to Mendeley  

    [PMID: ]   link to pdf   add to Mendeley  

Registering number (see trial on clinicaltrials.gov)
Code Name